| Novo Nordisk Pharma AG - Insulin NovoNordisk NovoRapid FlexPen, Injektionslösung | | 55712 | | 01 | | Insulin NovoNordisk NovoRapid FlexPen | | Injektionslösung | | A10AB05 | | Insulin aspart | | 08.12.2000 | | |
| | Composition | | insulinum aspartum 100 U.I., corresp. 3.5 mg, glycerolum, zinci chloridum, dinatrii phosphas dihydricus, natrii chloridum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, phenolum, metacresolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.216 mg. | | Packungsbestandteile | | Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Insuline Aspart | 100 UI |
| | BAG: Principe actif | Concentr. |
|---|
| Insuline Aspart | 100 U |
| | | | Agents auxilliaires |
|---|
| Acidum Hydrochloridum ad Ph | | Disodium Phosphate Dihydrate | | Glycerol | | Metacresol | | Sodium Chlorure | | Natrii Hydroxidum ad Ph | | Phenol | | Zinci Chlorure |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 5 x 3 ml | 36.93 | 56.60 | B | LS | Oui |
|
|
